Search for: "PFIZER PHARMACEUTICALS LLC"
Results 141 - 159
of 159
Sorted by Relevance
|
Sort by Date
30 May 2008, 9:09 am
: (Spicy IP), India: DCGI preparing document to implement patent-registration linkage: (Spicy IP), New Zealand: Generic pharmaceutical companies taking advantage of NZ IP laws and medicines regulations: (International Law Office), Uganda: Cipla licenses ARV technology into Uganda: (Afro-IP), US: Money saved through generic prescriptions: (GenericsWeb), US: Government plans to keep close tab on drug patent settlements: (GenericsWeb), US: FTC reports 14 deals to delay generics in 2007:… [read post]
29 Aug 2008, 1:25 pm
: (IP finance), Facebook removes international access to Scrabulous, except from India: (Ars Technica), (Techdirt), Reverse engineering can resolve conflict between standardisation and competition: (Techdirt), Benefits of piracy aren’t always in the expected places: (Techdirt) Events 1-3 September: Federation of Indian Chambers of Commerce and Industry, Department of Industrial Property and Promotion, and WIPO conference on ‘Development and IP: Building synergies… [read post]
10 Jan 2020, 9:32 am
Pfizer Pharmaceuticals, LLC, 730 F.3d 49 (1st Cir. 2013) (holding that district court erred in not applying the “reasonable certainty” test to a discretionary promotion). [read post]
31 Mar 2010, 1:58 pm
" Pfizer, Inc. v. [read post]
28 Apr 2011, 3:18 pm
By now Restatement (Second) of Torts §402A (1965) is so old as to be thought of as somewhat antediluvian. [read post]
24 Sep 2009, 5:09 am
We received a copy of Ford Motor Co. v. [read post]
28 Sep 2009, 1:31 am
We received a copy of Ford Motor Co. v. [read post]
15 Sep 2011, 5:00 am
LLC, 2011 WL 3666595, at *3 (W.D. [read post]
28 Sep 2009, 1:31 am
We received a copy of Ford Motor Co. v. [read post]
28 Sep 2009, 1:31 am
We received a copy of Ford Motor Co. v. [read post]
1 Feb 2023, 9:05 pm
Pfizer was a major contributor to the level of healthcare M&A, announcing a number of deals, including its $11.6 acquisition of Biohaven Pharmaceuticals, $5.4 billion acquisition of Global Blood Therapeutics and $525 million acquisition of ReViral. [read post]
27 Aug 2010, 2:41 pm
Ortho Pharmaceutical Corp., 209 Cal. [read post]
11 Apr 2008, 9:00 am
No problem…: Lundbeck A/S v Generics UK Ltd & Ors: (IPKat), Exelon (Rivastigmine Tartrate) – Dr Reddy’s and Novartis settle Exelon patent dispute: (Therapeutics Daily), GeneMaker – Codon Devices, Blue Heron Biotechnology settle patent suit over gene synthesis platform: (Patent Docs), Glucophage (Metformin) – Depomed settles patent litigation against IVAX: (SmartBrief), (IP Law360), (GenericsWeb), Lexapro (Escitalopram)… [read post]
2 May 2008, 7:00 am
: Lupin v Abbott Labs: (FDA Law Blog), Plavix (Clopidogrel) – US: Apotex sues FDA to recover 180-day exclusivity on generic Plavix: (Orange Book Blog), Plavix (Clopidogrel) – US: Former Bristol-Myers Squibb executive charged over lying about Plavix deal struck with rival Apotex: (Managing Intellectual Property), Risperdal (Resperidone) – US: Apotex files motion to intervene in relisting of Risperdal patent case; Teva quickly files opposition: Teva Pharma USA… [read post]
25 Apr 2015, 11:03 am
The first edition of the Reference Manual on Scientific Evidence [Manual] was published in 1994, a year after the Supreme Court delivered its opinion in Daubert. [read post]
3 May 2014, 8:56 am
Pfizer, Inc., 196 F. [read post]
13 Apr 2014, 8:59 am
Pfizer Canada Inc., [2012] 3 S.C.R. 625 The patent system is based on a “bargain”, or quid pro quo: the inventor is granted exclusive rights in a new and useful invention for a limited period in exchange for disclosure of the invention so that society can benefit from this knowledge. [read post]
15 Apr 2009, 4:44 am
Astrazenaca Pharmaceuticals, LP, 223 F.R.D. 659, 663-64 (M.D. [read post]
18 Sep 2008, 8:56 pm
The first edition of “Petitions to Watch” for the October 2008 term features cases up for consideration at the Justices’ opening conference of September 29. [read post]
